These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 92303)

  • 1. Detection of B cell antigens in multiple sclerosis. Use of serum from multiparous women.
    McFarlin DE; Mingioli ES; Behar TN; McFarland HF
    Arch Neurol; 1979 Dec; 36(13):819-22. PubMed ID: 92303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-typing and lymphocyte population studies in patients with multiple sclerosis.
    Reekers P; Hommes OR; Creemers-Molenaar J; Wijnings J; Kunst VA; Van Rood JJ
    J Neurol Sci; 1977 Aug; 33(1-2):143-53. PubMed ID: 71339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
    Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA and the response of lymphocytes to viral antigens in patients with multiple sclerosis.
    Walker JE; Cook JD; Harrison P; Stastny P
    Hum Immunol; 1982 Feb; 4(1):71-8. PubMed ID: 7061242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locus HLA-DR--specific antigens of B lymphocytes. Comprehensive review].
    Májský A
    Vnitr Lek; 1978 Nov; 24(11):1092-1101. PubMed ID: 82296
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA and Japanese MS.
    Naito S; Kuroiwa Y; Itoyama T; Tsubaki T; Horikawa A; Sasazuki T; Noguchi S; Ohtsuki S; Tokuomi H; Miyatake T; Takahata N; Kawanami S
    Tissue Antigens; 1978 Jul; 12(1):19-24. PubMed ID: 80838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and high incidence of a B lymphocyte antigen.
    Terasaki PI; Park MS; Opelz G; Ting A
    Science; 1976 Sep; 193(4259):1245-7. PubMed ID: 1085490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.
    Opelz G; Terasaki P; Myers L; Ellison G; Ebers G; Zabriskie J; Weiner H; Kempe H; Sibley W
    Tissue Antigens; 1977 Jan; 9(1):54-8. PubMed ID: 850918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis.
    Brautbar C; Cohen I; Kahana E; Alter M; Jorgensen F; Lamm L
    Tissue Antigens; 1977 Oct; 10(4):291-302. PubMed ID: 72427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-lymphocyte alloantigens associated with multiple sclerosis.
    Compston DA; Batchelor JR; McDonald WI
    Lancet; 1976 Dec; 2(7998):1261-5. PubMed ID: 63743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain.
    Pina MA; Ara JR; Lasierra P; Modrego PJ; Larrad L
    Neuroepidemiology; 1999; 18(4):203-9. PubMed ID: 10364721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HLA-D-linked low response to polyclonal B-cell activation in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Dossetor JB
    Transplant Proc; 1978 Dec; 10(4):973-5. PubMed ID: 366836
    [No Abstract]   [Full Text] [Related]  

  • 17. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular immunologic strategies to identify antigens and b-cell responses unique to multiple sclerosis.
    Gilden DH; Burgoon MP; Kleinschmidt-DeMasters BK; Williamson RA; Ghausi O; Burton DR; Owens GP
    Arch Neurol; 2001 Jan; 58(1):43-8. PubMed ID: 11176935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of HLA antigens in multiple sclerosis.
    Jersild C
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HL-A D antigens from B-lymphocytes and susceptibility to certain diseases].
    de Moerloose P; Chardonnens X; Vassalli P; Jeannet M
    Schweiz Med Wochenschr; 1977 Oct; 107(41):1461. PubMed ID: 303374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.